- Home
- BCAB vs EDUC Comparison
BCAB vs EDUC Comparison
Compare BCAB & EDUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCAB | EDUC |
|---|---|---|
| Founded | 2007 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Consumer Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 11.3M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BCAB | EDUC |
|---|---|---|
| Price | $0.18 | $1.35 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 18.5K |
| Earning Date | 06-15-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.19 | N/A |
| EPS | N/A | ★ 0.63 |
| Revenue | $300,000.00 | ★ $34,191,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.18 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $0.92 |
| 52 Week High | $1.43 | $1.84 |
Technical Indicators
Market Signals| Indicator | BCAB | EDUC |
|---|---|---|
| Relative Strength Index (RSI) | 41.77 | 50.24 |
| Support Level | $0.14 | $1.35 |
| Resistance Level | $0.27 | $1.44 |
| Average True Range (ATR) | 0.02 | 0.06 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 19.32 | 63.57 |
Price Performance
Historical ComparisonAbout BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.